Crossvault Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$1.25M Sell
20,295
-1,600
-7% -$98.9K 0.49% 39
2022
Q1
$1.3M Sell
21,895
-3,630
-14% -$216K 0.42% 42
2021
Q4
$1.85M Buy
25,525
+3,200
+14% +$232K 0.56% 41
2021
Q3
$1.56M Buy
22,325
+400
+2% +$27.9K 0.49% 40
2021
Q2
$1.5M Sell
21,925
-1,576
-7% -$108K 0.46% 42
2021
Q1
$1.52M Sell
23,501
-900
-4% -$58.2K 0.54% 40
2020
Q4
$1.42M Sell
24,401
-2,925
-11% -$170K 0.53% 40
2020
Q3
$1.73M Buy
27,326
+270
+1% +$17.1K 0.75% 35
2020
Q2
$2.08M Buy
27,056
+276
+1% +$21.2K 0.96% 29
2020
Q1
$2M Sell
26,780
-4,526
-14% -$338K 1.12% 28
2019
Q4
$2.03M Sell
31,306
-9,200
-23% -$598K 0.89% 31
2019
Q3
$2.57M Buy
40,506
+2,655
+7% +$168K 1.22% 27
2019
Q2
$2.56M Sell
37,851
-593
-2% -$40.1K 1.25% 26
2019
Q1
$2.5M Sell
38,444
-2,300
-6% -$150K 1.29% 25
2018
Q4
$2.55M Sell
40,744
-7,278
-15% -$455K 1.45% 24
2018
Q3
$3.71M Sell
48,022
-2,103
-4% -$162K 1.91% 20
2018
Q2
$3.55M Sell
50,125
-75
-0.1% -$5.31K 1.89% 21
2018
Q1
$3.79M Sell
50,200
-725
-1% -$54.7K 2.15% 19
2017
Q4
$3.65M Sell
50,925
-21,625
-30% -$1.55M 1.92% 22
2017
Q3
$5.88M Buy
72,550
+6,450
+10% +$523K 3.37% 10
2017
Q2
$4.68M Buy
66,100
+13,374
+25% +$947K 2.81% 17
2017
Q1
$3.58M Buy
52,726
+2,100
+4% +$143K 2.22% 22
2016
Q4
$3.63M Sell
50,626
-1,565
-3% -$112K 2.45% 20
2016
Q3
$4.13M Buy
52,191
+2,320
+5% +$184K 2.88% 15
2016
Q2
$4.16M Buy
49,871
+4,345
+10% +$362K 2.94% 14
2016
Q1
$4.18M Buy
45,526
+240
+0.5% +$22K 3.08% 14
2015
Q4
$4.58M Buy
45,286
+5,401
+14% +$546K 3.26% 9
2015
Q3
$3.92M Buy
39,885
+6,335
+19% +$622K 3.06% 14
2015
Q2
$3.93M Buy
33,550
+13,510
+67% +$1.58M 3.14% 13
2015
Q1
$1.97M Buy
20,040
+6,165
+44% +$605K 1.57% 27
2014
Q4
$1.31M Buy
+13,875
New +$1.31M 1.14% 32